AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
44.41
+1.11 (2.56%)
At close: Dec 5, 2025, 4:00 PM EST
44.35
-0.06 (-0.14%)
After-hours: Dec 5, 2025, 5:01 PM EST
AnaptysBio Market Cap
AnaptysBio has a market cap or net worth of $1.23 billion as of December 5, 2025. Its market cap has increased by 102.07% in one year.
Market Cap
1.23B
Enterprise Value
1.33B
1-Year Change
102.07%
Ranking
Category
Stock Price
$44.41
Market Cap Chart
Since January 26, 2017, AnaptysBio's market cap has increased from $308.70M to $1.23B, an increase of 297.79%. That is a compound annual growth rate of 16.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 1.23B | 204.79% |
| Dec 31, 2024 | 402.90M | -29.22% |
| Dec 29, 2023 | 569.20M | -35.40% |
| Dec 30, 2022 | 881.10M | -7.83% |
| Dec 31, 2021 | 955.90M | 62.57% |
| Dec 31, 2020 | 588.00M | 33.36% |
| Dec 31, 2019 | 440.90M | -74.16% |
| Dec 31, 2018 | 1.71B | -27.90% |
| Dec 29, 2017 | 2.37B | 666.67% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |